Abstract
Introduction

41
Newcastle disease virus (NDV) is a widely distributed virus that affects poultry and 42 other avian species [1] . NDV belongs to the order of Mononegavirals, family Based on the complete sequence of the F gene, NDV strains are classified into two 60 classes I and II [10] . Class I contains a single genotype, and strains have been isolated 61 mainly from wild birds and are generally lentogenic [10] . Class II contains at least 18 62 genotypes (I-XVIII), and they can be lentogenic, mesogenic or velogenic [10, 11] XII, respectively, but with the cytoplasmic tails from the parental rLS1 vector (Fig 1) . F 0 -
145
XII/CT-II differs from F 0 -XII in that the sequence corresponding to the cytoplasmic tail of 146 the F gene (29 amino acids at the C-terminal) was replaced by the one from the rLS1 strain. cultured with DMEM supplemented with 1% FBS and 5% AF with 5% CO2 at 37 ºC.
178
Supernatants were collected at 12, 24, 36, 48, 60 and 72 hours post-infection (hpi).
179
Collected supernatants were quantified in DF-1 cells by TCID50. . Viral shedding was assessed in the same way as described above.
228
Additionally, viral titers of HA positive swabs were calculated by plaque assay. NDVs. In rLS1-XII-1, complete F and HN genes were replaced in the rLS1 backbone for 242 those of the PP2011 strain. In rLS1-XII-2 only the ecto-and transmembrane domains were 243 replaced with those of PP2011. Both viruses were rescued and replicated in embryonated 244 eggs at 10 8.8 and 10 9.7 EID 50 /ml, respectively (see Table 2 ). However, it is worth to mention 245 that rLS1-XII-1 was detected by HA only after a second passage in embryonated eggs,
246
while rLS1-XII-2 was HA-positive after only one passage (directly inoculated from 247 transfection supernatant). Growth curves in DF-1 cells showed that parental rLS1 replicates 248 3.5 -81.3 and 0 -12.8 fold more compared to rLS1-XII-1 and rLS1-XII-2, respectively (Fig   249   2a ). At the 36 hpi, there was no difference in the replication between rLS1 and rLS1-XII-2.
250
Thus, in general, rLS1 replicates at higher titers than the rLS1-XII-2 and this one higher 251 than rLS1-XII-1. Additionally, immunofluorescence evaluated at 24, 48 and 72 hpi showed 252 that rLS1 and rLS1-XII-2 produce similar infection expansion patterns in monolayers of 253 DF-1 cells, while rLS1-XII-1 have a much more restricted spread in cells (Fig 2b) .
254
Accordingly, no clear cytopathic effect (CPE) or syncytia formation was observed in 255 monolayers infected with rLS1-XII-1, whereas rLS1 and rLS1-XII-2 presented the typical 256 CPE of NDV. This can explain the differences in growth curves between these strains. The ICPI value for the parental rLS1 was 0.1, while for chimeric viruses rLS1-XII-1 273 and rLS1-XII-2 were 0.0 ( vaccinated control group did not protect birds against mortality (Fig 3) . None of the 287 chickens in the rLS1 or rLS1-XII-2 groups showed any clinical signs, whereas in the rLS1- and rLS1-XII-2 (0/14 and 1/14 for oral and cloacal swabs, respectively) groups were less 292 than in rLS1-XII-1 group (9/13 and 9/13 for oral and cloacal swabs, respectively)
257
293
(supplementary S1 Table) . At 2nd and 4th dpc, 90% (9/10) and 100% (5/5) of the chickens in mock-vaccinated group were shedding virus (supplementary S1 Table) . showed that both vaccine viruses protected 100% chickens against mortality, while PBS 306 control group showed typical symptoms of velogenic NDV infection and had no survivors 307 after day 5 post-challenge (Fig 4a) . The shedding of challenged virus for immunized groups 308 was assessed from oral and cloacal swabs at 2, 4 and 7 dpc. As shown in Table 3 LaSota group (Fig 4b) . Therefore, compared with the commercial LaSota vaccine, rLS1- in vaccinated chickens at 14 and 28 dpv. *p < 0.05 and ***p<0.001. Genotype XII-specific serum neutralization titers taken at 14 or 28 dpv showed no 331 difference between rLS1-XII-2 and LaSota strains (Fig 4c) . However, the same samples 332 tested for genotype II-specific neutralizing antibodies showed that LaSota group was 333 significantly increased at 28 dpv (p = 0.031) and borderline significant at 14 dpv (p = 334 0.053) (Fig 4d) .
335
Discussion
336
Genotype XII is present in South America and is the prevalent circulating genotype 337 in Peru [10,13,15]. In our country, current vaccination strategies have shown to be not 338 sufficient to prevent outbreaks of the disease. This can be partially explained by antigenic 339 differences between circulating and vaccine strains (see Table 1 ). Hence, improvements of 340 vaccines and vaccination strategies are a priority. In this context, we decided to develop a 341 genotype XII-matched, live attenuated vaccine candidate. First, we generated two chimeric replication and, therefore, in protection. Genetically, the only difference between rLS1-XII-
356
1 and -2 is the presence of homologous cytoplasmic tails in the latter. Nonetheless, rLS1-
357
XII-1 has severely reduced the capacity of the virus to replicate (Fig 2) positions with respect to LaSota (Fig 5a) . This mutation (Ala549Thr) changes the charge of 
